GCP
TMO icon

Garda Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Garda Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,125
Closed -$1.08M – 685
2023
Q3 		$1.08M Buy
2,125
+1,630
+329% +$869K 0.05% 357
2023
Q2 		$258K Buy
+495
New +$267K 0.01% 322

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Garda Capital Partners's TMO Position: Q4 2023 in Review

Garda Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 2,125 shares — an estimated $1.08M sold.

Garda Capital Partners first reported a position in TMO in Q2 2023 and held it in 2 quarters. The position peaked at $1.08M in Q3 2023. 2,488 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • Garda Capital Partners reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
  • Garda Capital Partners sold 2,125 Thermo Fisher Scientific shares in Q4 2023, an estimated $1.08M.
  • Garda Capital Partners first reported a position in Thermo Fisher Scientific in Q2 2023 and held it in 2 quarters.
  • Garda Capital Partners's Thermo Fisher Scientific position peaked at $1.08M in Q3 2023.
  • 2,488 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Garda Capital Partners's 13F filing for Q4 2023, filed 12 Feb 2024.